Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:3
March, 2005
Dear Readers,
With the 18th Annual Symposium on Advanced Wound Care and the 15th Annual Medical Research Forum on Wound Repair scheduled for April 21–24 in San Diego, we are pleased to publish the 31 abstracts of clinical and research studies that were selected for oral presentation at the meeting. Also included in this issue is a partial listing of the exhibiting commercial companies and summaries of the products and services they provide.
In the article, An holistic approach to wound pain in patients with chronic wounds, Dr. Patricia Price discusses the importan
- Issue:3
I n recent years, there has been growing evidence that the experience of living with a chronic wound has a significant impact on a patient’s quality of life.1,2 A consistent finding, particularly in the qualitative work that has been completed, is that pain is a symptom patients find particularly distressing.3–5
A recent Canadian study6 suggests that the prevalence of pain in patients with pure or mixed venous ulcers is approximately 50%, with over 50% of these using analgesia as part of their treatment. Similar figures have been reported in other studie - Issue:3
L ocal anesthetics are divided into 2 main groups based on their chemical structure: amides and esters. Prilocaine (Citanest®, AstraZeneca Pharmaceuticals, Wilmington, Del) is a commonly used agent in infiltrative anesthesia, and its adverse effects are well known. It has been the least toxic of the presently used agents containing an aromatic benzene ring in their molecules.1,2
Adverse reactions from the amide group of local anesthetics are rare.3 Adverse reactions include toxic, psychosomatic, idiosyncratic, and allergic-pseudoallergic reactions. The likelihood of - Issue:3
F ull-thickness skin defects consist of loss of the entire epidermis and underlying dermis. This type of wound tends to heal by secondary intention in which contraction and angiogenesis, in addition to epithelization, gain importance. In this type of healing, inflammatory reaction is more intense, and larger amounts of granulation tissue form compared with healing by primary intention. The increased contribution of myofibroblasts supports the contraction that takes place in this healing process. Additionally, circulatory and metabolic status is important in influencing wound closure.1
- Issue:3
Presentation
A 49-year-old White female was referred for evaluation of a warty lesion, which had been present on her abdomen for 3 months. It had not responded to liquid nitrogen treatment or over-the-counter wart treatments. The lesion had gradually become more irritated and had increased in size. The patient had a 10-year history of rheumatoid arthritis and ankylosing spondylitis.
The patient’s medications included immunosuppressive treatments, including prednisone for 10 years, adalimumab (Humira, Abbott Laboratories, Abbott Park, Ill) for 2 years, and nabumetone (Relafen, GlaxoSmit - Issue:3
RegeneRx Cleared to Initiate Phase II Clinical Trial with TB4 for Epidermolysis Bullosa
RegeneRx Biopharmaceuticals, Inc. (Bethesda, Md) announces it is clear to begin its third Phase II clinical trial to test its drug, Thymosin beta 4 (TB4), for the treatment of patients with epidermolysis bullosa (EB). “We are pleased we are able to proceed according to our clinical development plan,” said David Crockford, Head of Clinical and Regulatory Affairs for RegeneRx. “Epidermolysis bullosa represents a unique opportunity for RegeneRx, both from a scientific and business perspective. The ab
- Issue:3
FLA Orthopedics Introduces the HealWell® Soft Ease™ Heel Suspender
FLA Orthopedics (Miramar, Fla), a manufacturer of orthopedic, sports medicine, and bracing products, introduces the HealWell® Soft Ease™ Multi-AFO/Heel Suspender that positions the foot with the heel completely suspended, eliminating pressure and preventing ulcers. The shape allows the heel to float in an air cavity and promotes air circulation around the foot, aiding in the treatment and healing of existing ulcers. The plastic shell base correctly positions the foot for treatment of foot drop and non-fixed ankle/foot
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
